References
deLorimier A, Park F, Aranha GV, Reyes C. Hepatoid carcinoma of the stomach. Cancer. 1993;71:293–6.
Inagawa S, Shimazaki J, Hori M, Yoshimi F, Adachi S, Kawamoto T, et al. Hepatoid adenocarcinoma of the stomach. Gastric Cancer. 2001;4:43–52.
Ishikura H, Fukasawa Y, Ogasawara K, Natori T, Tsukada Y, Aizawa M. An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report. Cancer. 1985;56:840–8.
Arnould L, Drouot F, Fargeot P, Bernard A, Foucher P, Collin F, et al. Hepatoid adenocarcinoma of the lung: report of a case of an unusual alpha-fetoprotein-producing lung tumor. Am J Surg Pathol. 1997;21:1113–8.
Hayashi Y, Takanashi Y, Ohsawa H, Ishii H, Nakatani Y. Hepatoid adenocarcinoma in the lung. Lung Cancer. 2002;38:211–4.
Ishikura H, Ishiguro T, Enatsu C, Fujii H, Kakuta Y, Kanda M, et al. Hepatoid adenocarcinoma of the renal pelvis producing alpha-fetoprotein of hepatic type and bile pigment. Cancer. 1991;67:3051–6.
Hoshida Y, Nagakawa T, Mano S, Taguchi K, Aozasa K. Hepatoid adenocarcinoma of the endometrium associated with alpha-fetoprotein production. Int J Gynecol Pathol. 1996;15:266–9.
Yamamoto R, Ishikura H, Azuma M, Hareyama H, Makinoda S, Koyama Y, et al. Alpha-fetoprotein production by a hepatoid adenocarcinoma of the uterus. J Clin Pathol. 1996;49:420–2.
Kato K, Suzuka K, Osaki T, Itami M, Tanaka N. Primary hepatoid adenocarcinoma of the uterine cervix. Int J Gynecol Cancer. 2007;17:1150–4.
Lee CH, Huang KG, Ueng SH, Swei H, Chueh HY, Lai CH. A hepatoid carcinoma of the ovary. Acta Obstet Gynecol Scand. 2002;81:1080–2.
Ozan H, Oztürk Nazlioğlu H, Ozuysal S. A case of hepatoid carcinoma of the ovary. Eur J Gynaecol Oncol. 2008;29:556–7.
Paner GP, Thompson KS, Reyes CV. Hepatoid carcinoma of the pancreas. Cancer. 2000;88:1582–9.
Hughes K, Kelty S, Martin R. Hepatoid carcinoma of the pancreas. Am Surg. 2004;70:1030–3.
Hameed O, Xu H, Saddeghi S, Maluf H. Hepatoid carcinoma of the pancreas: a case report and literature review of a heterogeneous group of tumors. Am J Surg Pathol. 2007;31:146–52.
Watanabe M, Hori Y, Nojima T, Kato H, Taketa K, Isogawa S, et al. Alpha-fetoprotein-producing carcinoma of the gallbladder. Dig Dis Sci. 1993;38:561–4.
Vardaman C, Albores-Saavedra J. Clear cell carcinomas of the gallbladder and extrahepatic bile ducts. Am J Surg Pathol. 1995;19:91–9.
Nakashima H, Nagafuchi K, Satoh H, Takeda K, Yamasaki T, Yonemasu H, et al. Hepatoid adenocarcinoma of the gallbladder. J Hepatobiliary Pancreat Surg. 2000;7:226–30.
Sakamoto K, Monobe Y, Kouno M, Moriya T, Sasano H. Hepatoid adenocarcinoma of the gallbladder: case report and review of the literature. Pathol Int. 2004;54:52–6.
Sakamoto K, Kimura N, Tokumura H, Ogasawara T, Moriya T, Sasano H. Hepatoid adenocarcinoma of the gallbladder. Histopathology. 2005;47:649–51.
Koswara T, Marwoto W, Siregar NC, Gumay S, Azis H, Abdullah M, et al. Hepatoid carcinoma of the gallbladder. Acta Med Indones. 2007;39:179–82.
Gakiopoulou H, Givalos N, Liapis G, Agrogiannis G, Patsouris E, Delladetsima I. Hepatoid adenocarcinoma of the gallbladder. Dig Dis Sci. 2007;52:3358–62.
van den Bos IC, Hussain SM, Dwarkasing RS, Stoop H, Zondervan PE, Krestin GP, et al. Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma. Br J Radiol. 2007;80:e317–20.
Brumm C, Schulze C, Charels K, Morohoshi T, Klöppel G. The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours. Histopathology. 1989;14:503–13.
Maitra A, Murakata LA, Albores-Saavedra J. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract. Am J Clin Pathol. 2001;115:689–94.
Takeyama H, Sawai H, Wakasugi T, Takahashi H, Matsuo Y, Ochi N, et al. Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases. World J Surg Oncol. 2007;5:79.
Guan YS, He Q. Sorafenib: activity and clinical application in patients with hepatocellular carcinoma. Expert Opin Pharmacother. 2011;12:303–13.
Keating GM, Santoro A. Sorafenib: a review of its use in advanced hepatocellular carcinoma. Drugs. 2009;69:223–40.
Lord R, Suddle A, Ross PJ. Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies. Int J Clin Pract. 2011;65:182–8.
Rossi L, Zoratto F, Papa A, Iodice F, Minozzi M, Frati L, et al. Current approach in the treatment of hepatocellular carcinoma. World J Gastrointest Oncol. 2010;2:348–59.
Shibata Y, Sato K, Kodama M, Nanjyo H. Alpha-fetoprotein-producing early gastric cancer of the remnant stomach: report of a case. Surg Today. 2007;37:995–9.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karayiannakis, A.J., Kakolyris, S., Giatromanolaki, A. et al. Hepatoid Adenocarcinoma of the Gallbladder. J Gastrointest Canc 43 (Suppl 1), 139–144 (2012). https://doi.org/10.1007/s12029-011-9326-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-011-9326-5